The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.

Cancer Med · 2021 · PMC8446554 · PMID 34464516

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The frequency of anti‐SARS‐CoV‐2 positive patients taking nilotinib was numerically higher than that of cases treated with other TKIs (Figure 1 ), but the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.